Implantable Collamer Lens Market Report 2025

This Implantable Collamer Lens market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The implantable collamer lens market size has grown strongly in recent years. It will grow from $19.53 billion in 2024 to $20.91 billion in 2025 at a compound annual growth rate (CAGR) of 7.10%. The growth observed during the historical period can be attributed to factors such as increased awareness of vision correction options, the growing adoption of minimally invasive surgeries, a rise in the prevalence of refractive errors, favorable reimbursement policies in key regions, and increased investment in ophthalmic research.

The implantable collamer lens market size is expected to see strong growth in the next few years. It will grow to $27.25 billion in 2029 at a compound annual growth rate (CAGR) of 6.84%. In the forecast period, growth is expected to be driven by rising demand for permanent vision correction solutions, a higher prevalence of myopia and astigmatism, a growing focus on customized and patient-specific implants, an aging population with greater eye care needs, and the expansion of outpatient surgical centers. Key trends in the forecast period include the integration of AI in preoperative planning, the development of foldable and biocompatible lens materials, collaborations between manufacturers and healthcare providers, technological advancements in lens materials and designs, and progress in implantable lens technology.

The increasing prevalence of vision disorders is expected to significantly boost the growth of the implantable collamer lens (ICL) market. Vision disorders, which include conditions affecting the ability to see clearly, are becoming more common globally due to factors such as an aging population, increased screen time, and the rising incidence of conditions such as myopia and age-related macular degeneration. Implantable collamer lenses offer an effective solution to correct vision disorders such as myopia, hyperopia, and astigmatism, providing a safe and reversible alternative to traditional refractive surgeries such as LASIK. According to the World Health Organization (WHO), over 2.2 billion people worldwide suffer from near or distance vision impairment, with 1 billion cases being preventable or unaddressed. Additionally, the Welsh Government reported a 49.1% rise in new vision impairment certifications, further highlighting the growing demand for effective vision correction solutions. This trend is driving the growth of the implantable collamer lens market.

The aging population is another major factor driving the growth of the implantable collamer lens market. As life expectancy increases and birth rates decline, the proportion of elderly individuals is rising globally, leading to greater demand for vision correction solutions for age-related issues such as presbyopia. Implantable collamer lenses are particularly beneficial for the aging population, offering a permanent solution to presbyopia that eliminates the need for reading glasses or contact lenses. For example, in 2022, individuals aged 65 and over made up about 19% of the UK's population, and this is expected to grow to 27% by 2072. This demographic shift is fueling demand for ICLs, further contributing to market growth.

Key players in the implantable collamer lens market are focusing on advancing lens technology and obtaining approvals to remain competitive. One such innovation is the EVO/EVO+ Visian Implantable Collamer Lens (ICL), approved by the U.S. Food and Drug Administration (FDA) in April 2022. Developed by STAAR Surgical Company, the EVO Visian ICL is designed to correct myopia and myopia with astigmatism, providing a minimally invasive solution to vision correction. The lens is capable of addressing myopia ranging from -3 D to -20 D and astigmatism between 1 D and 4 D, offering a highly effective treatment for a wide range of vision issues. Innovations such as these are transforming the vision correction landscape and enhancing the growth prospects for the implantable collamer lens market.

The key company operating in the implantable collamer lens market are STAAR Surgical Company.

North America was the largest region in the implantable collamer lens market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in implantable collamer lens report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the implantable collamer lens market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Implantable collamer lenses (ICLs), also known as implantable contact lenses, are a type of refractive lens implant designed to treat various eye conditions. They function similarly to contact lenses, but instead of being worn on the surface of the eye, they are surgically inserted in front of the natural lens and behind the iris, which is the colored part of the eye.

The primary types of implantable collamer lenses are the Visian implantable collamer lens (ICL) and the EVO implantable collamer lens (ICL). The Visian ICL is a phakic intraocular lens used to correct vision problems such as myopia, hyperopia, and astigmatism, providing a reversible and biocompatible alternative to LASIK surgery. These lenses incorporate technologies such as laser-assisted and traditional techniques. They are mainly used for treating myopia, hyperopia, and astigmatism and are utilized by various end users, including ophthalmic clinics, hospitals, ambulatory surgical centers, and other healthcare facilities.

The implantable collamer lens market research report is one of a series of new reports that provides implantable collamer lens market statistics, including the implantable collamer lens industry global market size, regional shares, competitors with the implantable collamer lens market share, detailed implantable collamer lens market segments, market trends, and opportunities, and any further data you may need to thrive in the implantable collamer lens industry. This implantable collamer lens market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The implantable collamer lens (ICL) market consists of sales of lenses, ICL delivery systems, surgical equipment, and preoperative diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.